Forecast: Chronic Obstructive Pulmonary Diseases Mortality in the US

In 2023, the chronic obstructive pulmonary diseases (COPD) mortality rate in the US stood at 50.5 units (male deaths) per hundred thousand men, standardized rates. The forecasted data from 2024 to 2028 suggest a stable yet slightly increasing trend in mortality rates, with an average increase of around 0.1 units per year. The year-on-year variation indicates near-constant growth of approximately 0.2% each year over this period. The compound annual growth rate (CAGR) over the next 5 years shows a minimal but consistent upward trend in COPD mortality rates.

Future trends to watch for include the impact of emerging treatments and public health initiatives aimed at reducing smoking rates and exposure to pollutants. Additionally, advancements in early diagnosis and management of COPD could potentially alter the trajectory of this trend, emphasizing the need for continual monitoring and adaptive healthcare strategies.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease